3.9 Article Proceedings Paper

Acute respiratory distress syndrome secondary to inhalation of chlorine gas in sheep

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.ta.0000205862.57701.48

Keywords

chlorine; inhalation injury; acute respiratory distress syndrome; sheep; multiple inert gas elimination technique; computed tomography

Ask authors/readers for more resources

Background:. Toxic industrial chemicals (TICs) are potential terrorist weapons. Several TICs, such as chlorine, act primarily on the respiratory tract, but knowledge of the pathophysiology and treatment of these injuries is inadequate. This study aims to characterize the acute respiratory distress syndrome (ARDS) caused by chlorine gas (Cl-2) inhalation in a large-animal model. Methods: Anesthetized female sheep were ventilated with 300 L of a Cl-2/air/oxygen mixture for 30 minutes. In phase 1 (n = 35), doses were 0 ppm (Group 1, n = 6); 120 ppm (Group 2, n = 6); 240 to 350 ppm (Group 3, n 11); and 400 to 500 ppm (Group 4, n = 12). In phase 2 (n = 17), doses were 0 ppm (Group 5, n = 5); 60 ppm (Group 6, n = 5); and 90 ppm (Group 7, n = 7), and the multiple inert gas elimination technique (MIGET) was used to characterize the etiology of hypoxemia. Computed tomography (CT) scans were performed daily for all animals. Results:. In Phase 1, lung function was well maintained in Group 1; Cl, caused immediate and sustained acute lung injury (Pao(2)-to-FiO(2) ratio, PFR < 3.0) in Group 2 and ARDS (PFR < 2.0) in Groups 3 and 4. All animals in Groups 1 and 2 survived 96 hours. Kaplan-Meier analysis showed dose-related differences in survival (log-rank test, p < 0.0001). Logistic regression identified 280 ppm as the lethal dose 50%. CT and histopathology demonstrated lesions of both small airways and alveoli. In Phase 2, MIGET showed diversion of blood flow from normal to true-shunt lung compartments and, transiently, to poorly ventilated compartments. Conclusions: Cl-2 causes severe, dose-related lung injury, with features seen in both smoke inhalation and in ARDS secondary to systemic disease. This model will be used to test new therapeutic modalities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available